Toronto, Ontario–(Newsfile Corp. – October 22, 2026) – Vimy Pharmaceuticals Inc. (“Vimy Pharma” or the “Company”) and Harmony Acquisitions Corp. (TSXV: MONY.P) (“Harmony”) are pleased to jointly announce that, further to their joint news release dated September 28, 2026, the Company has completed the second tranche (the “Second Tranche”) of its previously announced “best efforts” brokered private placement through the issuance of 827,533 subscription receipts of the Company (each, a…
